Natera, Inc.

NTRA Healthcare Diagnostics & Research

Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.

Revenue
+34.1%
EPS
+34.4%
Free cash flow
−85.8%
Total debt
−0.06%

Quarter to September 2026, against a year earlier

311.66 52.10 −14.32%
Market cap
$52.4B
P/E
0.0×
Fwd P/E
−289×
Dividend yield
—
F-score
6/9
Altman Z
26.84
Beneish M
−2.17
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 5 Nov
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
13.58 11.32 14.37 20.47
P/FCF ratio
287.05 270.78 461.93 1,134.89
P/Operating CF
423.90 704.46 709.82 1,355.41
P/B ratio
18.29 15.95 21.35 31.85
EV/Sales
13.27 11.03 14.10 20.22
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
280.55 263.88 453.32 1,121.08
Current Ratio
3.39 2.96 3.00 2.81
Net Debt/EBITDA
114.60 13.75 18.52 0.00
Debt/Equity
0.05 0.05 0.04 0.04
Earnings Yield
(0.67%) (0.82%) (0.50%) (0.28%)
Free Cash Flow Yield
0.35% 0.37% 0.22% 0.09%
Free Cash Flow per Share
0.28 0.13 (0.06) 0.04
Book value per Share
12.52 12.54 12.71 12.98
Free Cash Flow
37.82 18.03 (8.64) 5.25
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026